Mangoceuticals Inc (MGRX) stock shows 52-week fluctuation between $0.98 and $6.15

Abby Carey

A share price of Mangoceuticals Inc [MGRX] is currently trading at $1.22, up 1.67%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MGRX shares have gain 10.91% over the last week, with a monthly amount drifted -3.17%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Mangoceuticals Inc experienced fluctuations in its stock price throughout the past year between $0.98 and $6.15. Mangoceuticals Inc [NASDAQ: MGRX] shares were valued at $1.22 at the most recent close of the market.

Analyzing the MGRX fundamentals

Trailing Twelve Months sales for Mangoceuticals Inc [NASDAQ:MGRX] were 0.47M which represents -36.83% decline. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at -44.37%, Pretax Profit Margin comes in at -45.47%, and Net Profit Margin reading is -45.47%. To continue investigating profitability, this company’s Return on Assets is posted at -1.2, Equity is -1.15 and Total Capital is -1.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1433 points at the first support level, and at 1.0665 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.2734, and for the 2nd resistance point, it is at 1.3267.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Mangoceuticals Inc [NASDAQ:MGRX] is 0.74. Also, the Quick Ratio is 0.74, while the Cash Ratio stands at 0.6. Considering the valuation of this stock, the price to sales ratio is 36.10, the price to book ratio is 1.08.

Transactions by insiders

Recent insider trading involved JOHNSTON EUGENE M, CFO, that happened on Dec 15 ’25 when 3333.0 shares were sold. CFO, JOHNSTON EUGENE M completed a deal on Dec 09 ’25 to sell 5000.0 shares. Meanwhile, CFO JOHNSTON EUGENE M sold 10000.0 shares on Dec 05 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.